Home/Filings/4/0000950170-24-024970
4//SEC Filing

Burgess Justin 4

Accession 0000950170-24-024970

CIK 0001029142other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:25 PM ET

Size

14.1 KB

Accession

0000950170-24-024970

Insider Transaction Report

Form 4
Period: 2024-03-01
Burgess Justin
VP Finance & CAO
Transactions
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2024-03-014,3348,666 total
    Exercise: $11.12Exp: 2030-02-15Common Stock (0 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-01$11.12/sh+4,334$48,19417,759 total
  • Exercise/Conversion

    Common Stock

    2024-03-01$9.41/sh+2,767$26,03720,526 total
  • Sale

    Common Stock

    2024-03-01$12.78/sh7,101$90,75113,425 total
  • Sale

    Common Stock

    2024-03-01$12.78/sh13,425$171,5720 total
  • Exercise/Conversion

    StockOptions (Right to Buy)

    2024-03-012,7670 total
    Exercise: $9.41Exp: 2028-02-02Common Stock (0 underlying)
Footnotes (5)
  • [F1]Code M - Exercise or conversion of derivative security
  • [F2]Code S - Open market or private sale of non-derivative or derivative security
  • [F3]This transaction was executed in multiple trades at prices ranging from $12.73 to $12.81; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
  • [F4]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 16, 2023, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
  • [F5]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 3, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

Documents

1 file

Issuer

DYNAVAX TECHNOLOGIES CORP

CIK 0001029142

Entity typeother

Related Parties

1
  • filerCIK 0001812025

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:25 PM ET
Size
14.1 KB